Literature DB >> 9778072

Heart failure after aortic valve replacement for aortic regurgitation: prospective 20-year study.

M P Tornos1, M Olona, G Permanyer-Miralda, A Evangelista, J Candell, F Padilla, J Soler Soler.   

Abstract

BACKGROUND: The objective of this study was to assess the probability of development of heart failure during a long-term follow-up in patients submitted for aortic valve replacement for aortic regurgitation on the basis of preoperative findings. METHODS AND
RESULTS: Eighty-seven consecutive patients with pure aortic regurgitation and normal coronary arteries were submitted for aortic valve replacement and prospectively followed up. Clinical examination, echocardiography, and radionuclide ejection fraction were performed before surgery and at 1, 2, 5, and 10 years after surgery. Operative mortality rate was 2.2% (2 patients). The follow-up period was 1 to 12 years (mean 6 years). Overall survival rate was 87% at 5 years and 81% at 10 years. During follow-up, 19 patients had heart failure develop, and there were 14 deaths (6 caused by heart failure). Probability of heart failure was 16% at 5 years and 24% at 10 years. Age was the single independent preoperative predictor of both death and heart failure. Age >50 years (relative risk [RR] 10.4), preoperative ejection fraction <40% (RR 10.6), and end-systolic diameter >50 mm (RR 74) were independently related to the postoperative development of heart failure.
CONCLUSIONS: Aortic valve replacement can be performed safely in patients with severe aortic regurgitation by following current recommendations. Age >50, end-systolic diameter >50 mm, and radionuclide ejection fraction <40% were independent preoperative predictors of postoperative heart failure. The only independent predictor of both postoperative death and heart failure was age >50 years.

Entities:  

Mesh:

Year:  1998        PMID: 9778072     DOI: 10.1016/s0002-8703(98)70016-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

Review 1.  Biochemical markers of myocyte injury in heart failure.

Authors:  Y Sato; T Kita; Y Takatsu; T Kimura
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 2.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Authors:  Tal Geva
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-20       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.